• Product name
  • Description
    Rabbit polyclonal to Gliomedin
  • Host species
  • Specificity
    ab24483 detects a Gliomedin sized band at 70kDa in WB.
  • Tested applications
    Suitable for: WB, ICC/IFmore details
  • Species reactivity
    Reacts with: Mouse, Rat
    Predicted to work with: Human
  • Immunogen

    Synthetic peptide conjugated to KLH derived from within residues 250 - 350 of Rat Gliomedin.

    Read Abcam's proprietary immunogen policy (Peptide available as ab25746.)

  • Positive control
    • This antibody gave a positive signal in the following tissue lysates: Sciatic Nerve (Rat and Mouse) IF/ICC: PC12 cell line



Our Abpromise guarantee covers the use of ab24483 in the following tested applications.

The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.

Application Abreviews Notes
WB Use at an assay dependent concentration. Detects a band of approximately 70 kDa (predicted molecular weight: 59 kDa).Can be blocked with Rat Gliomedin peptide (ab25746).
ICC/IF Use a concentration of 10 µg/ml.


  • Relevance
    Gliomedin is a member of the collagen superfamily, it is a glial ligand for neurofascin and NrCAM, two axonal immunoglobulin cell adhesion molecules that are associated with Na+ channels at the nodes of Ranvier. Gliomedin provides a glial cue for the formation of peripheral nodes of Ranvier. Gliomedin is expressed by myelinating Schwann cells and accumulates at the edges of each myelin segment during development, where it aligns with the forming nodes of ranvier. Eliminating the expression of gliomedin or the addition of a soluble extracellular domain of neurofascin to myelinating cultures abolishes node formation. Gliomedin is expressed in the PNS nodes of ranvier, but not in the CNS nodes of ranvier. Gliomedin also displays high expression in murine and human hepatocellular carcinomas (HCC). Its restricted expression in normal tissues and unique early upregulation during tumor development make it an excellent candidate as a new clinical marker of HCC.
  • Cellular localization
    Cell Membrane and Cytoplasmic
  • Database links
  • Alternative names
    • Cancer related gene-Liver 2 antibody
    • CLOM antibody
    • collomin antibody
    • Colm (gene name) antibody
    • COLM antibody
    • Colmedin antibody
    • CRG L2 antibody
    • CRGL2 antibody
    • FLJ23917 antibody
    • Gldn (gene name) antibody
    • UNC 112 antibody
    see all


  • All lanes : Anti-Gliomedin antibody (ab24483) at 1 µg/ml

    Lane 1 : Mouse Sciatic Nerve Tissue Lysate
    Lane 2 : Rat Sciatic Nerve Tissue Lysate

    Lysates/proteins at 10 µg per lane.

    All lanes : Goat Anti-Rabbit IgG H&L (HRP) preadsorbed at 1/50000 dilution

    Developed using the ECL technique.

    Performed under reducing conditions.

    Predicted band size: 59 kDa
    Observed band size: 70 kDa
    why is the actual band size different from the predicted?

    Exposure time: 4 minutes

    ab24483 detects a band of 70 kDa in Western Blot. Gliomedin contains a number of N-glycosylation sites (SwissProt data) which may explain the migration at a higher molecular weight than predicted based on primary sequence.

  • ICC/IF image of ab24483 stained PC12 cells. The cells were 100% methanol fixed (5 min) and then incubated in 1%BSA / 10% normal goat serum / 0.3M glycine in 0.1% PBS-Tween for 1h to permeabilise the cells and block non-specific protein-protein interactions. The cells were then incubated with the antibody (ab24483, 10µg/ml) overnight at +4°C. The secondary antibody (green) was ab96899, DyLight® 488 goat anti-rabbit IgG (H+L) used at a 1/250 dilution for 1h. Alexa Fluor® 594 WGA was used to label plasma membranes (red) at a 1/200 dilution for 1h. DAPI was used to stain the cell nuclei (blue) at a concentration of 1.43µM.


This product has been referenced in:
  • Kwon HS  et al. Myocilin mediates myelination in the peripheral nervous system through ErbB2/3 signaling. J Biol Chem 288:26357-71 (2013). Read more (PubMed: 23897819) »
  • Kawamura N  et al. Anti-neurofascin antibody in patients with combined central and peripheral demyelination. Neurology 81:714-22 (2013). Human . Read more (PubMed: 23884033) »
See all 4 Publications for this product

Customer reviews and Q&As

There are currently no Customer reviews or Questions for ab24483.
Please use the links above to contact us or submit feedback about this product.


Sign up